Acetylcholine and necroptosis are players in follicular development in primates by Du, Yongrui et al.
1SCieNtifiC REPORts |  (2018) 8:6166  | DOI:10.1038/s41598-018-24661-z
www.nature.com/scientificreports
Acetylcholine and necroptosis are 
players in follicular development in 
primates
Yongrui Du1,2, Konstantin Bagnjuk3, Maralee S. Lawson1, Jing Xu1,4 & Artur Mayerhofer3
Acetylcholine (ACh) in the ovary and its actions were linked to survival of human granulosa cells in vitro 
and improved fertility of rats in vivo. These effects were observed upon experimental blockage of the 
ACh-degrading enzyme (ACH esterase; ACHE), by Huperzine A. We now studied actions of Huperzine A 
in a three-dimensional culture of macaque follicles. Because a form of programmed necrotic cell death, 
necroptosis, was previously identified in human granulosa cells in vitro, we also studied actions of 
necrostatin-1 (necroptosis inhibitor). Blocking the breakdown of ACh by inhibiting ACHE, or interfering 
with necroptosis, did not improve the overall follicle survival, but promoted the growth of macaque 
follicles from the secondary to the small antral stage in vitro, which was correlated with oocyte 
development. The results from this translational model imply that ovarian function and fertility in 
primates may be improved by pharmacological interference with ACHE actions and necroptosis.
Acetylcholine (ACh) is known as an important neurotransmitter of the central and the peripheral nervous 
systems. Its actions are mediated by nicotinic and muscarinic receptors. In addition, ACh is also produced by 
non-neuronal cells in various organ systems. Roles of non-neuronal ACh are emerging in the skin, the respiratory 
system, the cardiovascular system, the immune systems and the reproductive system1–4.
In the ovary, granulosa cells are producers and targets of ACh5,6. Previous studies, mainly using cultured 
granulosa cells collected from patients undergoing in vitro fertilization, implicated ACh in the regulation of cell 
viability and proliferation. ACh induced muscarinic receptor-mediated elevations of intracellular Ca2+ levels and 
transcription factor expression, activation of ion channels and breakdown of gap junction communication, which 
resulted in trophic, growth-promoting actions4,7–10. Studies in mice indicated that follicle-stimulating hormone 
(FSH) stimulated ACh production by granulosa cells11. Thus, ACh could participate in mediating FSH-actions in 
the avascular compartment of the ovary. Studies in the bovine corpus luteum were also in line and supported the 
trophic action of ACh in the ovary12.
In neurons, ACh is cleaved and deactivated by acetylcholinesterase (ACHE). ACHE was also expressed by 
granulosa cells collected from patients undergoing in vitro fertilization13. Blocking ACHE activity by a potent 
and selective inhibitor, Huperzine A, consequently enhanced granulosa cell survival in culture13. A subsequent 
systemic study in rats demonstrated that Huperzine A, when applied locally to the ovarian bursa, increased 
intra-ovarian ACh levels and promoted specifically the growth of preantral follicles to the early antral stage14. 
Furthermore, the treatment significantly enhanced antral follicle maturation, ovulation and fertility outcomes. 
Since ACHE blockers are commonly used in the treatment of Alzheimer’s disease15, they could be explored as 
agents to facilitate ovarian follicular development via regulating granulosa cell viability and proliferation.
The study mentioned above13 also led to the insight that cultured human granulosa cells can die not only 
by apoptosis, but also by necroptosis, i.e. programed necrotic cell death, which was not previously described in 
ovarian cells13,16–19. Necroptosis involves necrosome assembly, i.e., a cascade of interacting kinases cumulating in 
the execution of necrotic cell death. Interfering with activities of necrosome components, e.g., by necrostatin-1, 
1Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Oregon Health & 
Science University, 505 NW 185th Avenue, Beaverton, Oregon, 97006, USA. 2Department of Reproductive Medicine, 
Tianjin Central Hospital of Gynecology Obstetrics, No 156 Nankai Sanma Road, Nankai District, Tianjin, 300100, 
China. 3BMC Munich, Cell Biology, Anatomy III, Ludwig-Maximilians-University, Grosshaderner Str. 9, D-82152, 
Planegg, Martinsried, Germany. 4Department of Obstetrics and Gynecology, School of Medicine, Oregon Health 
& Science University, 3181 SW Sam Jackson Park Road, Portland, Oregon, 97239, USA. Yongrui Du, Konstantin 
Bagnjuk, Jing Xu and Artur Mayerhofer jointly supervised this work. Correspondence and requests for materials 
should be addressed to A.M. (email: Mayerhofer@lrz.uni-muenchen.de)
Received: 28 November 2017
Accepted: 4 April 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCieNtifiC REPORts |  (2018) 8:6166  | DOI:10.1038/s41598-018-24661-z
inhibited necroptosis in cultured human granulosa cells13. While the existence of necroptosis in the rodent ovary 
remains to be determined, follicular expression of phosphorylated mixed lineage kinase domain-like protein 
(MLKL), pMLKL(S358) as a necroptosis marker, was detected in the human and nonhuman primate antral fol-
licles by immunohistochemistry13. This implies physiological relevance of necroptosis in the primate ovary. It 
remains to be studied, which factors trigger ovarian necroptosis19. Although necroptosis occurred in cultured 
granulosa cells, there are no insights into its regulation, aside from a peptide derived from a splice variant of 
ACHE, namely “read-through variant” (ACHE-R)20,21, which enhanced this process13.
Based on the results obtained in human granulosa cells and in the systemic rat study, additional experiments were 
designed, in which the consequences of (1) pharmacological manipulation of ACh breakdown and (2) interference with 
necroptosis were studied in nonhuman primate growing follicles from the secondary to the small antral stage in vitro.
Results
Huperzine A treatment. Under control conditions, in vitro-developed macaque antral follicles produced 
ACh, which was detectable in the culture media. Huperzine A addition during culture increased (P < 0.05) media 
concentrations of ACh compared with the vehicle control group (1.23 ± 0.09 versus 0.93 ± 0.06 µM; n = 26 and 
17 follicles from 5 animals, respectively).
The percentage of rhesus macaque follicles that survived relative to the total number cultured was 56 ± 9% in 
the vehicle control group at culture week 5. Huperzine A addition had no effect on follicle survival after 5 weeks 
of culture (58 ± 11%) compared with controls.
Rhesus macaque follicles that survive in vitro can be divided into distinct cohorts based on their growth by 
week 5 as previously described22. While non-growing follicles remained at the preantral stage throughout 5 weeks 
of culture, growing follicles formed an antrum at week 3. The percentages of growing versus total surviving fol-
licles were comparable between the vehicle control and Huperzine A group (50 ± 7 versus 73 ± 13%). However, 
though starting with equivalent sizes in the beginning of culture, growing follicles attained larger (P < 0.05) diam-
eters at week 5 of culture in the Huperzine A group compared with those of the vehicle control group (Fig. 1A). 
Growing follicles with diameters ≥ 500 μm at culture week 5 were termed as fast-grow follicles, as previously 
Figure 1. The effects of Huperzine A and necrostatin-1 on rhesus macaque follicle growth after 5 weeks of 
culture in an alginate matrix. Follicle growth was presented as follicle diameters (A) and as percentages of fast-
grow follicles (diameter ≥ 500 μm) versus total growing follicles (B). CTRL, vehicle control; HupA, Huperzine 
A addition; Nec1, necrostatin-1 addition. *Significant difference between treatment groups (P < 0.05). Data are 
presented as the mean ± SEM with 18–31 follicles and 5 animals per experimental group.
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described22. There were no significant differences between the vehicle control and Huperzine A group on the 
percentages of fast-grow versus total growing follicles at culture week 5 (Fig. 1B).
Following 5 weeks of culture, hematoxylin and eosin staining of follicles (the largest sections of follicles to 
show the relative follicle diameters and the thickness of follicle walls) from the vehicle control (Fig. 2A and D) and 
Huperzine A (Fig. 2B and E) groups revealed a morphology similar to that observed in in vivo-developed small 
antral follicles in primates23, in terms of a spherical shape with an oocyte and an antral cavity, multiple layers of 
granulosa cells and an intact basement membrane.
In vitro-developed macaque antral follicles produce appreciable amounts of ovarian steroid hormones, includ-
ing progesterone (P4), androstenedione (A4) and estradiol (E2), into the culture media, as reported previously22. 
Huperzine A addition did not statistically alter media P4, A4 or E2 concentrations produced by growing follicles 
compared with those of the vehicle controls at culture week 5 (P4: 11 ± 4 versus 8 ± 4 ng/ml; A4: 3 ± 2 versus 
5 ± 3 pg/ml; E2: 487 ± 175 versus 289 ± 88 pg/ml).
Healthy, germinal vesicle stage oocytes surrounded by cumulus cells were obtained from in vitro-developed 
macaque antral follicles after 5 weeks of culture in the vehicle control and Huperzine A groups (Fig. 3A). 
Huperzine A treatment did not alter the oocyte diameters relative to the control group (Fig. 3B).
Necrostatin-1 treatment. Neither the follicle survival rates nor the percentage of growing versus total 
surviving follicles at culture week 5 were altered by necrostatin-1 treatment relative to the vehicle control group 
(survival: 64 ± 10 versus 56 ± 9%; growth: 69 ± 15 versus 50 ± 7%). However, diameters of growing follicles at 
culture week 5 were larger (P < 0.05) in the necrostatin-1 group than those of the vehicle control group (Fig. 1A). 
In addition, percentages of fast-grow follicles were greater (P < 0.05) following necrostatin-1 exposure compared 
with those of the vehicle controls (Fig. 1B). Hematoxylin and eosin staining at culture week 5 showed that follicles 
cultured with necrostatin-1 had an extensively developed granulosa layer (Fig. 2C and F) relative to follicles in the 
vehicle control group (Fig. 2A and D).
There were no statistically significant differences between the vehicle control and necrostatin-1 group on the media 
concentrations of P4 (8 ± 4 versus 5 ± 2 ng/ml), A4 (5 ± 3 versus 2 ± 2 pg/ml) or E2 (289 ± 88 versus 723 ± 265 pg/ml) 
produced by growing follicles at culture week 5. In vitro-developed macaque antral follicles in the necrostatin-1 group 
produced healthy, germinal vesicle stage oocytes surrounded by cumulus cells. Compared with the vehicle controls, the 
oocyte diameters at week 5 increased (P < 0.05) in follicles following necrostatin-1 exposure (Fig. 3B).
Figure 2. In vitro-developed rhesus macaque follicles following 5 weeks of culture in an alginate matrix with 
exposure of the control vehicle (A), Huperzine A (B) and necrostatin-1 (C) were stained with hematoxylin and 
eosin, respectively (D,E,F). OO, oocyte. Scale bar = 100 µm.
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Expression of ACHE and of necrosome components. The mRNA expression of ACHE and the necro-
some components (MLKL, receptor-interacting serine/threonine-protein kinase 1 or RIPK1) were detected in 
in vivo-developed macaque secondary and antral follicles (Fig. 4). In vitro-developed antral follicles from all 4 
macaques expressed ACHE, MLKL, RIPK1, as identified by RT-PCR (Fig. 4). Amplicon identities were confirmed 
by sequencing.
In addition, RIPK1 and RIPK3 proteins were readily detected in the preantral and antral follicles, mainly 
in granulosa cells, of macaque ovaries by immunohistochemistry (Fig. 5A). Granulosa cells of some in 
vivo-developed macaque follicles were stained for pMLKL(S358) (Fig. 5A). Positive immunostaining of pMLK-
L(S358) was also detected in the cytoplasm of granulosa cells in in vitro-developed antral follicles from all 4 
macaques (Fig. 5B). No pMLKL(S358)-positive staining was evident in negative control sections (Fig. 5A and C) 
or in vitro-developed antral follicles cultured with necrostatin-1 (Fig. 5D).
Discussion
The present study utilized a three-dimensional follicle culture system22 to explore roles of ACh and necrop-
tosis during primate follicular development. Pharmacological inhibition of ACh-breakdown was achieved by 
ACHE-blocker Huperzine A. Necroptosis was inhibited by intercepting RIPK1 actions using necrostatin-1. Both 
approaches enhanced follicular development from the secondary to the small antral stage in vitro. The results 
Figure 3. The effects of Huperzine A and necrostatin-1 on oocyte growth in rhesus macaque antral follicles 
after 5 weeks of culture in an alginate matrix. Oocytes obtained were surrounded by cumulus cells (A; 
representative from the vehicle control group). Oocyte growth was determined by measuring oocyte diameters. 
CC, cumulus cells; CTRL, vehicle control; HupA, Huperzine A addition; Nec1, necrostatin-1 addition. 
*Significant difference between treatment groups (P < 0.05). Data are presented as the mean ± SEM with 18–31 
oocytes per experimental group. Scale bar = 25 µm.
Figure 4. RT-PCR analysis on the expression of acetylcholinesterase (ACHE), mixed lineage kinase domain-
like protein (MLKL), receptor-interacting serine/threonine-protein kinase 1 (RIPK1) by in vivo-developed 
secondary and antral follicles pooled from 4 macaques, respectively, as well as by in vitro-developed antral 
follicles (under control culture conditions) from 4 individual macaques. Electrophoresis and Midori Green 
staining were performed using the same protocol for all gels. Results were cropped and grouped. Original gels 
are provided in the supplemental dataset.
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of the present study performed in a translational model reveal previously unknown roles for ACh/ACHE and 
necroptosis in follicular development, and indicate that pharmacological agents, which target these processes, 
may be suitable to enhance follicular development.
ACh production and some of its actions were previously identified in granulosa cells of the ovarian follicle. 
ACh acted via muscarinic receptors, which were detected in macaque and human ovarian follicles4. Downstream 
actions studied in human granulosa cells included among others breakdown of gap junctions and increasing 
proliferation7,8. Further studies in granulosa cells obtained from patients undergoing in vitro fertilization demon-
strated the positive impact of ACh on cell viability in culture13. The addition of Huperzine A, which blocks ACHE 
actions24, generated similar outcomes13. In a follow-up systemic study in rats, Huperzine A administration to 
the ovarian bursa elevated ovarian ACh levels, specifically enhanced the growth of preantral follicles, improved 
ovulation, and increased overall fertility14. When the same concentration of Huperzine A was used for macaque 
follicle culture in the present study, it promoted follicle growth from the secondary to the small antral stage, as 
indicated by larger follicle diameters, implying a trophic action of ACh in granulosa cells. ACh levels produced 
by in vitro-developed follicles increased following Huperzine A treatment, as demonstrated in the current study, 
and higher bioavailable ACh stimulated granulosa cell proliferation and viability in macaque follicles, which is 
consistent with previous studies.
The previous study in rats14 showed that Huperzine A treatment increased the number of small antral fol-
licles in vivo. However, in our current study, blocking ACHE actions did not increase the overall survival of 
macaque follicles developed in vitro, which could be due to the fact that follicle survival involves both granulosa 
cell and oocyte viability. Oocytes may have an important role in regulating follicular development25. In this con-
text, expression of receptors for ACh in rhesus macaque preovulatory follicle-derived oocytes7 indicates that the 
oocyte could be a direct target of ACh. Future studies are warranted to determine whether oocytes from preantral 
and small antral follicles are affected by ACh and what the outcomes are.
Figure 5. Immunohistochemical detection of necroptosis-related proteins in macaque ovarian follicles. 
Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and 3 (RIPK3) were identified in in vivo-
developed preantral (1), small antral (2) and large antral (3) follicles, mainly in granulosa cells (GC) (A). 
Granulosa cells of some follicles were stained for phosphorylated mixed lineage kinase domain-like protein, 
pMLKL(S358) (A). Positive staining of pMLKL(S358) was also detected in the granulosa cells of in vitro-
developed small antral follicles cultured under control conditions (B; arrows), but not in the negative controls 
(A,C) or follicles cultured with necrostatin-1 (D). Counterstaining was performed using haematoxylin.
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Once ovarian follicles start to grow, they either reach the preovulatory stage or undergo atresia. Apoptosis 
of oocytes and granulosa cells has been intensively studied and is suggested to be the underlying mechanism of 
follicular atresia throughout species26,27. Recently, necroptosis was described in cultured human granulosa cells13, 
which could be intercepted by drugs targeting the necrosome16. In human granulosa cells, the RIPK1 inhibitor 
necrostatin-1 and the MLKL blocker necrosulfonamide reduced necroptosis significantly13. A specific marker 
pMLKL(S358) was detected in human and macaque granulosa and luteal cells, which provided first evidence of 
necroptosis in the primate ovary13.
Consistently, the present study demonstrated expression of the necrosome components MLKL and RIPK1 in 
macaque follicles developed in vivo and in vitro. RIKP1, RIPK3 and pMLKL(S358) proteins were also detected 
in macaque ovarian follicles. The presence of pMLKL(S358) clearly indicated ongoing necroptosis in macaque 
follicles. To further explore involvement of necroptosis in follicular development, necrostatin-1 was introduced 
into the follicle culture system with the same concentration as what was used in human granulosa cell culture13. 
Macaque secondary follicles cultured in the presence of necrostatin-1 grew larger than the control follicles as 
indicated by increased follicle diameters, greater percentages of fast-grow follicles and well-developed granulosa 
layers. Therefore, besides apoptosis, necroptosis appears to be an important additional mechanism in regulating 
follicular cell death, at least in the primate ovary.
Although diameters of in vitro-developed antral follicles increased following either Huperzine A or 
necrostatin-1 exposure, more fast-grow follicles were obtained only from the necrostatin-1 group containing 
oocytes with larger diameters. It could be due to a suboptimal dose of Huperzine A employed, the greater impact 
of necroptosis in follicular growth, in general. These points, which are the heart of the question how follicular 
growth is regulated, require additional studies. Growth of follicles is also reflected by active E2 production by 
well-developed granulosa cells, specifically in the necrostatin-1-treated follicles, though the differences in media 
E2 levels did not reach statistical significance. Results from the current study suggest that inhibition of necrop-
tosis has the potential to promote primate follicular development, which may be used to improve outcomes of in 
vitro follicle maturation protocols.
Several ACHE-blockers are used clinically for the treatment of Alzheimer’s disease15,28,29. Necroptosis-blockers 
are being developed and tested for treatment of various medical conditions15. It appears conceivable that these 
agents could also be used to manipulate follicular development, either by enhancing granulosa cell proliferation 
or by interfering with granulosa cell necroptosis. Studies are warranted to explore their effectiveness in treatment 
of ovarian dysfunction.
It is not clear whether the cholinergic system in the ovary6 is affected by circulating ACHE or the related 
enzyme, butyrylcholine-esterase (BCHE). Both enzymes break down ACh and were active in human follicular 
fluid13. ACHE and BCHE increase in the circulation with age in women30. Hence, it seems that changes in the cir-
culating levels of these enzymes could be superimposing factors affecting the fate of ovarian follicles by lowering 
available ACh. The age-related decline of the functional ovarian reserve is thought to be a consequence of follicu-
lar atresia, which ultimately leads to depletion of the ovarian follicle pool, and hence, menopause26,27,31. Studies 
are now warranted to explore the involvement of ACh/ACHE and necroptosis in the process of follicular atresia.
In summary, both Huperzine-A and necrostatin-1 promoted overall follicular development during encapsu-
lated three-dimensional culture in rhesus macaques, presumably by fostering granulosa cell proliferation (actions 
of elevated ACh) and limiting granulosa cell necroptosis (actions of interference with RIPK1). The results reveal, 
for the first time, the importance of local ACh and necroptosis in the regulation of primate folliculogenesis, which 
supports the potential of pharmacological interference of ACHE actions and necroptosis as novel approaches to 
improve ovarian functions in women.
Methods
Animal use and ovary collection. The general care and housing of rhesus macaques (Macaca mulatta) 
were provided by the Division of Comparative Medicine, Oregon National Primate Research Center (ONPRC), 
Oregon Health & Science University, as previously described22. Animals were pair-caged in a temperature-con-
trolled (22 °C), light-regulated (12 L: 12D) room. The diet consisted of Purina monkey chow (Ralston-Purina, 
Richmond, IN, USA) and was provided twice a day supplemented with fresh fruit or vegetables once a day. Water 
was provided ad libitum. Animals were treated according to the National Institutes of Health’s Guide for the Care 
and Use of Laboratory Animals. Protocols were approved by the ONPRC Institutional Animal Care and Use 
Committee22.
Ovaries were collected from 5 animals at necropsy (8–14 year old) by the Pathology Services Unit, via the 
ONPRC Tissue Distribution Program. Euthanasia was not performed for the current study, but was due to health 
issues unrelated to reproductive health. Ovaries were immediately transferred into HEPES-buffered holding 
media (Cooper Surgical, Inc., Trumbull, CT, USA) and kept at 37 °C for follicle isolation32.
Follicle isolation, encapsulation and culture. The process of follicle isolation, encapsulation and culture 
was previously reported22. Briefly, the ovarian cortex was cut into 1 × 1 × 1 mm cubes. Follicles were mechanically 
isolated using 31-gauge needles. Secondary follicles (diameter 125–225 μm) met criteria for encapsulation if they 
exhibited an intact basement membrane, 2–4 layers of granulosa cells and a healthy centrally located oocyte.
Follicles were individually transferred into 5 µl 0.25% (w/v) sterile sodium alginate (FMC BioPolymers, 
Philadelphia, PA, USA)-PBS (137 mM NaCl, 10 mM phosphate, 2.7 mM KCl, Invitrogen, Carlsbad, CA, USA). 
The droplets were gelled in 50 mM CaCl2, 140 mM NaCl, 10 mM HEPES solution (pH 7.2). Each encapsulated 
follicle was placed in individual wells of 48-well plates containing 300 µl alpha minimum essential medium 
(Invitrogen) containing 6% (v/v) human serum protein supplement (Cooper Surgical, Inc.), 0.5 mg/ml bovine 
fetuin, 5 µg/ml insulin, 5 µg/ml transferrin, 5 ng/ml sodium selenite (Sigma-Aldrich, St Louis, MO, USA), and 
3 ng/ml recombinant FSH (NV Organon/Merck Sharp & Dohme, Oss, Netherlands)22.
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Follicles from each of the five animals were randomly assigned to 3 experimental groups (12 follicles/monkey/
group): (a) vehicle control (0.025% ethanol), (b) 10 µM Huperzine A (42643; Sigma-Aldrich), and (c) 20 µM 
necrostatin-1 (sc-200142; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). Follicles were cultured at 37 °C 
in a 5% O2 environment (in 6% CO2/89% N2) for 5 weeks. Media (150 µl) was collected and replaced every other 
day, and stored at −20 °C22.
Follicle survival and growth. Follicle survival, growth and antrum formation were assessed weekly using 
an Olympus CK-40 inverted microscope and an Olympus DP11 digital camera (Olympus Imaging America Inc., 
Center Valley, PA, USA), as described previously22. Follicle growth was determined by measuring the distance 
from the outer layer of cells at the widest diameter and then the diameter perpendicular to the first measurement 
by the same individual. The mean of the two values determined the follicle’s overall diameter. The measurements 
were performed using ImageJ 1.6.0 software (National Institutes of Health, Bethesda, MD, USA). Follicles were 
considered atretic if the oocyte was dark or not surrounded by a layer of granulosa cells, the granulosa cells 
appeared dark or fragmented, or the follicle diameter decreased.
Follicle histology. Randomly selected in vitro-developed antral follicles from all three groups were harvested 
at culture week 5 and fixed in in 4% paraformaldehyde-PBS solution for 3 hours at room temperature. Follicles 
were embedded in HistoGel (Thermo Scientific, Kalamazoo, MI, USA) before being dehydrated in ascend-
ing concentrations of ethanol (70–100%) and embedded in paraffin. Five micrometer sections were cut by the 
Histopathology-Morphology Research Core at ONPRC, and stained with hematoxylin and eosin as previously 
described22.
Culture media assays. To determine the efficiency of Huperzine A in blocking ACHE actions in cultured 
follicles, media samples from the control and the Huperzine A group were analyzed for ACh concentrations using 
the Amplex Red Acetylcholine/Acetylcholinesterase Assay Kit (A12217; Molecular Probes, Inc., Eugene, OR, 
USA) according to the manufacturer’s instruction, as described previously33.
In order to assess steroidogenesis in cultured follicles, media samples collected from each culture group were 
analyzed for P4, A4 and E2 concentrations by the Endocrine Technologies Core at ONPRC. P4 and E2 were 
assayed to determine granulosa cell steroidogenic function using an Immulite 2000, a chemiluminescence-based 
automatic platform (Siemens Healthcare Diagnostics, Deerfield, IL, USA)22. A4 was measured by ELISA to deter-
mine thecal cell steroidogenic function using an AA E-1000 kit (Rocky Mountain Diagnostics, Inc., Colorado 
Springs, CO, USA) according to the manufacturer’s instruction22.
Oocyte evaluation. Oocyte evaluations were performed on a 37 °C warming plate, as previously described22. 
Briefly, the cumulus-oocyte complex was dissected out of the follicle in Tyrode’s albumin lactate pyruvate 
(TALP)-HEPES-BSA (0.3% v/v) medium provided by the Assisted Reproductive Technologies Core at ONPRC. 
Oocytes were then transferred to TALP medium and photographed. Oocyte diameters (excluding the zona pellu-
cida) and conditions were assessed using the same camera and software, as described above.
Expression of ACHE and necrosome components in macaque follicles. This retrospective study 
included follicles obtained from animals (n = 4) reported in previous research34. Briefly, in vivo-developed sec-
ondary (30 follicles/monkey) and antral (10 follicles/monkey) follicles were isolated from the cortex and the 
medulla region of macaque ovaries, respectively, and pooled. In vitro-developed antral follicles were collected 
at the end of culture under control conditions and pooled (10 follicles/monkey). Total RNA was extracted from 
each follicle pool for reverse transcription, as previously described34. Oligonucleotide primers for PCR (Table 1) 
were designed using Primer335,36 and synthesized by metabion international AG (Planegg, Germany). PCR was 
performed to examine expression of ACHE, MLKL and RIPK1, as described previously13. PCR products were 
sequenced by GATC Biotech AG (Konstanz, Germany) and analyzed using BLAST37.
Consecutive sections from paraffin-embedded rhesus macaque ovaries (n = 3) obtained from previous stud-
ies11,13 were used for immunohistochemistry with antibodies detecting RIPK1 (HPA015257; Sigma-Aldrich), 
RIPK3 (HPA055087; Sigma-Aldrich) and pMLKL(S358) (ab187091; Abcam, Cambridge, UK), as previously 
described13. Randomly selected paraffin embedded antral follicles (4 follicles from 4 macaques), developed under 
Target gene Direction Sequence
Macaca mulatta
fitness Accession number
MLKL
Forward 5′- TAC AGT CAG CAG AGT GCA GG -3′ 85% H. sapiens
NM_152649.2 M.Mulatta
XM_015126624.1Reverse 5′- ACC GTT TGT GGA TGA CCT GG -3′ 95%
RIPK1
Forward 5′- TGG GCG TCA TCA TAG AGG AAG -3′ 100% H. sapiens
NM_003804 M.Mulatta
XM_015135439.1Reverse 5′- CGC CTT TTC CAT GTA AGT AGC A -3′ 100%
ACHE
Forward 5′- TTC CTC AGT GAC ACC CCA GA -3′ 100% H. sapiens
NM_000665.4
M. Mulatta
NM_001128088.2
Reverse 5′- GGG GAG AAG AGA GGG GTT AC -3′ 100%
Table 1. Information about oligonucleotid primers used for RT-PCR. Note that primers were designed 
using Homo sapiens RNA sequences. Except MLKL forward (85%) and MLKL reverse (95%), all primers are 
100% identical to Macaca mulatta sequences. Sequences of PCR products obtained matched Macaca mulatta 
sequences as confirmed upon sequencing.
www.nature.com/scientificreports/
8SCieNtifiC REPORts |  (2018) 8:6166  | DOI:10.1038/s41598-018-24661-z
control culture conditions34, were obtained for sectioning and immunohistochemistry for pMLKL(S358). To 
determine the efficiency of necrostatin-1 in blocking necroptosis in cultured follicles, in vitro-developed antral 
follicles harvested from the necrostatin-1 group at week 5 were also stained for pMLKL(S358). Controls were 
performed with the omission of antibodies or using non-immune serum.
Statistical analysis. Statistical analysis was performed using SigmaPlot 11 software (SPSS, Inc., Chicago, 
IL, USA). Because follicles from each animal were randomly distributed into the culture groups, the Wilcoxon 
signed-rank test was used to evaluate differences in follicle survival and percentage of fast-grow follicles, with 
five individual animals in each experimental group. One-way analysis of variance (ANOVA), followed by the 
Student-Newman-Keuls post hoc test, was used to analyze diameters of follicles and oocytes, as well as media hor-
mone concentrations, with total follicle numbers indicated in the figure legends which represent follicles obtained 
from five individual animals. Media ACh concentrations were analyzed using a Student’s t-test. Differences were 
considered significant at P < 0.05 and values are presented as mean ± SEM.
Data availability. Data generated during this study are included in this published article and supplementary 
files. The original raw datasets generated during the current study are available from the corresponding author 
on reasonable request.
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